[ACRX] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
16-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -13.29%
YoY- -14.85%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 252 2 738 475 613 740 6,435 -41.71%
PBT -7,485 -7,917 -8,918 -14,423 -12,558 -10,588 -9,682 -4.19%
Tax -1 467 698 885 355 -703 68 -
NP -7,484 -7,917 -8,918 -14,423 -12,558 -9,885 -9,682 -4.19%
Tax Rate - - - - - - - -
Total Cost 7,736 7,919 9,656 14,898 13,171 10,625 16,117 -11.50%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -2,969.84 -395,850.00 -1,208.40 -3,036.42 -2,048.61 -1,335.81 -150.46 64.35%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -1.01 -1.24 -1.93 -3.63 -3.56 -3.88 -4.27 -21.35%
EPS Diluted -1.01 -1.24 -1.93 -3.63 -3.56 -3.88 -4.27 -21.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.